The rise of TIM-3: A promising immune target in diffuse midline gliomas

Clin Transl Med. 2024 Jan;14(1):e1536. doi: 10.1002/ctm2.1536.

Authors

Iker Ausejo-Mauleon^{1

2

3}, Sara Nuin^{1

2

3}, Marta M Alonso^{1

2

3}

Affiliations

¹ Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.
² Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain.
³ Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Brain Neoplasms* / genetics
Glioma* / genetics
Hepatitis A Virus Cellular Receptor 2 / genetics
Humans

Substances

Hepatitis A Virus Cellular Receptor 2

Grants and funding

817884/European Union's Horizon 2020 Research and Innovation Programme